Purpose: To assess whether gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging could predict hepatocellular carcinoma (HCC) diagnosis in small arterial enhancing-only nodules detected by contrast-enhanced computed tomography (CT) in patients with liver cirrhosis. Materials and Methods: We prospectively recruited 125 cirrhotic patients (67 males, and 58 females; age: 68 6 12.36 years) with 151 small (<2 cm in diameter) arterial enhancing-only nodules identified by contrast-enhanced CT. All patients were scanned by MR imaging before and after Gd-BOPTA injection during the hepatic arterial phase (HAP), portal venous phase (PVP), equilibrium phase (EP), and hepatobiliary phase (HP). Nodule characterization was based on reference imaging crite...
Purpose: To analyze Gd-EOB-DTPA-enhanced magnetic resonance (MR) findings of nodules (low-grade dysp...
Purpose: To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during ...
none7noBackground: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnet...
Purpose: To assess whether gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging could predict hepat...
Purpose: To assess whether gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging could predict hepat...
OBJECTIVE: The purpose of this article is to assess whether unenhanced and gadobenate dimeglumine-en...
OBJECTIVE: The purpose of this article is to assess whether unenhanced and gadobenate dimeglumine-en...
PURPOSE: To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during ...
OBJECTIVES: To evaluate the value of 1-hour delayed phase imaging (DPI) of gadobenate dimeglumine (G...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
Purpose: To define the percentage of small (\ua32 cm) hepatocellular carcinoma (HCC) nodules showing...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
PURPOSE: To analyze Gd-EOB-DTPA-enhanced magnetic resonance (MR) findings of nodules (low-grade dysp...
To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during the hepat...
Purpose: To define the percentage of small (\ua32 cm) hepatocellular carcinoma (HCC) nodules showing...
Purpose: To analyze Gd-EOB-DTPA-enhanced magnetic resonance (MR) findings of nodules (low-grade dysp...
Purpose: To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during ...
none7noBackground: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnet...
Purpose: To assess whether gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging could predict hepat...
Purpose: To assess whether gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging could predict hepat...
OBJECTIVE: The purpose of this article is to assess whether unenhanced and gadobenate dimeglumine-en...
OBJECTIVE: The purpose of this article is to assess whether unenhanced and gadobenate dimeglumine-en...
PURPOSE: To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during ...
OBJECTIVES: To evaluate the value of 1-hour delayed phase imaging (DPI) of gadobenate dimeglumine (G...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
Purpose: To define the percentage of small (\ua32 cm) hepatocellular carcinoma (HCC) nodules showing...
Background: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnetic reso...
PURPOSE: To analyze Gd-EOB-DTPA-enhanced magnetic resonance (MR) findings of nodules (low-grade dysp...
To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during the hepat...
Purpose: To define the percentage of small (\ua32 cm) hepatocellular carcinoma (HCC) nodules showing...
Purpose: To analyze Gd-EOB-DTPA-enhanced magnetic resonance (MR) findings of nodules (low-grade dysp...
Purpose: To evaluate whether gadoxetic acid (Gd-EOB-DTPA)-enhanced MR images of tumors taken during ...
none7noBackground: Gadoxetic acid (Gd-EOB-DTPA) is a “hepatocyte-specific” contrast agent for magnet...